These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26665557)

  • 21. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
    Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score.
    Torlakovic E; Lilleby W; Torlakovic G; Fosså SD; Chibbar R
    Hum Pathol; 2002 Jun; 33(6):646-51. PubMed ID: 12152165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.
    Oliai BR; Kahane H; Epstein JI
    Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.
    Grover SK; Agarwal S; Gupta S; Wadhwa N; Sharma N
    Pathol Oncol Res; 2015 Jul; 21(3):651-7. PubMed ID: 25527409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
    Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
    Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?
    Bera KN; Yadav SK; Prakash O; Singh S; Sarin N
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S30-S33. PubMed ID: 32108623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
    Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
    Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
    Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAGI-2 in prostate cancer: an immunohistochemical study.
    Goldstein J; Borowsky AD; Goyal R; Roland JT; Arnold SA; Gellert LL; Clark PE; Hameed O; Giannico GA
    Hum Pathol; 2016 Jun; 52():83-91. PubMed ID: 26980016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
    Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
    Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
    Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
    Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of androgen receptor in prostatic neoplasia versus hyperplasia.
    Husain I; Shukla S; Soni P; Husain N
    J Cancer Res Ther; 2016; 12(1):112-6. PubMed ID: 27072221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma.
    Söderström KO; Laato M; Wu P; Hopsu-Havu VK; Nurmi M; Rinne A
    Int J Cancer; 1995 Jul; 62(1):1-4. PubMed ID: 7541394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.